Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: An analysis of an integrated healthcare database

Journal of Thrombosis and Thrombolysis

Volumn 32, Issue 1, 2011, Pages 89-95

  Merli, G J ^a   Malangone, E ^b   Lin, J ^c   Lamerato, L ^d   Stern, L ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b Analytica International   (United States)

^c SANOFI   (France)

^d HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Guidelines; Hip arthroplasty; Knee a.rthroplasty.; Prophylaxis; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIP ARTHROPLASTY; HOSPITAL PATIENT; HUMAN; INTEGRATED HEALTH CARE SYSTEM; INTERNATIONAL NORMALIZED RATIO; KNEE ARTHROPLASTY; LENGTH OF STAY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MEDICAL PRACTICE; OUTCOME ASSESSMENT; OUTPATIENT; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; THROMBOSIS PREVENTION; TREATMENT DURATION; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DATABASES, FACTUAL; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 80052428615     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0554-0     Document Type: Article

References (18)

1. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW, American College of Chest Physicians (2008) Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest 133(6 Suppl):381S-453S (Pubitemid 351894916)
2. Sweetland S, Green J, Liu B, Berrington de González A, Canonico M, Reeves G, Beral V, Million Women Study collaborators (2009) Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 339:b4583
3. American Academy of Orthopaedic Surgeons (2007) Clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty, adopted by the American Academy of Orthopedic Surgeons Board of Directors May 2007. http://www.aaos.org/research/guidelines/PE-guideline. pdf. Accessed 21 Oct 2010
4. Amin A, Spyropoulos AC, Dobesh P, Shorr A, Hussein M, Mozaffari E, Benner JS (2010) Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). J Thromb Thrombolysis 29:326-339
5. Amin AN, Stemkowski S, Lin J, Yang G (2008) Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis? Thromb Haemost 99:796-797 (Pubitemid 351694244)
6. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr, ENDORSE Investigators (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371:387-394 (Pubitemid 351173321)
7. Kakkar AK, Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Deslandes B, Huang W, Anderson FA Jr, ENDORSE Investigators (2010) Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg 251:330-338
8. Friedman RJ, Gallus AS, Cushner FD, Fitzgerald G, Anderson FA Jr, Global Orthopaedic Registry Investigators (2008) Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty. Curr Med Res Opin 24:87-97 (Pubitemid 351160242)
9. Yu HT, Dylan ML, Lin J, Dubois RW (2007) Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 64:69-76 (Pubitemid 46395711)
10. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, Turibio FM (2007) Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br 89:799-807 (Pubitemid 47180202)
11. Anderson FA Jr, Hirsh J, White K, Fitzgerald RH Jr, Hip, Knee Registry Investigators (2003) Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 124(16 Suppl):349S-356S (Pubitemid 38005461)
12. Clagett GP, Anderson FA Jr, Geerts W et al (1998) Prevention of venous thromboembolism. Chest 114(5 Suppl):531S-560S. doi:10.1378/chest.114.5- Supplement.531S (Pubitemid 28535780)
13. Geerts WH, Heit JA, Clagett GP, Heit JA, Knudson M, Lieberman JR, Merli GJ, Wheeler HB (2001) Prevention of venous thromboembolism. Chest 119(1 Suppl):132S-175S (Pubitemid 32162075)
14. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 Suppl):338S-400S (Pubitemid 39302602)
15. Clagett GP, Anderson FA Jr, Heit J, Levine MN, Wheeler HB (1995) Prevention of venous thromboembolism. Chest 108(4 Suppl):312S-334S
16. Colorado Foundation for Medical Care. Surgical Care Improvement Project (SCIP). www.cfmc.org/hospital/hospital-scip.htm. Accessed 21 October 2010
17. Amin AN, Lin J, Johnson BH, Schulman KL (2010) Clinical and economic outcomes with appropriate or partial prophylaxis. Thromb Res 125:513-517
18. U.S. Department of Health & Human Services. Centers for Medicare & Medicaid Services: Reporting Hospital Quality Data for Annual Payment Update. www.cms.hhs.gov/HospitalQualityInits/08-HospitalRHQDAPU.asp. Accessed 21 Oct 2010